Formats
  1. Journal Article (66748)
  2. Meeting Abstract (33620)
  3. Book Section (5027)
  4. Review (3743)
  5. Editorial (2162)
  6. Conference Paper (1525)
  7. Correspondence (661)
  8. Guidelines (661)
  9. Research Letter (548)
  10. Miscellaneous (339)
  11. Book Whole (338)
Groups
  1. Department of Medicine (39034)
  2. GSK Faculty (22468)
  3. Solid Tumor Oncology Division (22057)
  4. Surgery (21249)
  5. Sloan Kettering Institute Faculty (16086)
  6. Survivorship Research (15763)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Robert Motzer (1243)
  3. Victor Reuter (1228)
  4. Howard Scher (1130)
  5. Murray Brennan (1059)
  6. Sergio Giralt (1050)

More People

Years
  1. 2025 (1982)
  2. 2024 (5377)
  3. 2023 (5804)
  4. 2022 (6168)
  5. 2021 (5712)
  6. 2020 (5599)

More Years

Publications
  1. Journal of Clinical Oncology (8590)
  2. Blood (4950)
  3. Cancer Research (2701)
  4. International Journal of Radiation Oncology, Biology, Physics (2610)
  5. Laboratory Investigation (1879)
  6. Modern Pathology (1812)

More Publications

Publishers
  1. Elsevier Inc. (13855)
  2. American Society of Clinical Oncology (9157)
  3. Springer (7152)
  4. Nature Publishing Group (6367)
  5. American Association for Cancer Research (6002)
  6. Elsevier Science, Inc. (5503)

More Publishers

Results (115372)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Comparison of neuropsychological functioning in pediatric posterior fossa tumor survivors: Medulloblastoma, low-grade astrocytoma, and healthy controls
    Meeting Abstract

    Levitch, C.; Holland, A. A.; Bledsoe, J.; Kim, S. Y.; Barnett, M.; Ramjan, S.; Sands, S.
    Neuro-Oncology (2022)

    Fulltext@MSK | Save
  • Laser interstitial thermal therapy as a radiation-sparing approach for children with cancer predisposition
    Meeting Abstract

    Guadix, S.; de Silva, N.; Souweidane, M.
    Neuro-Oncology (2022)

    Fulltext@MSK | Save
  • Durability of an early management strategy facilitating endoscopic removal of recurrent choroid plexus carcinoma
    Meeting Abstract

    Guadix, S.; Garman, T.; Pisapia, D.; Souweidane, M.
    Neuro-Oncology (2022)

    Fulltext@MSK | Save
  • A novel epigenetic nanotherapeutic strategy to induce medulloblastoma differentiation
    Meeting Abstract

    Raju, P.; Tylawsky, D.; Vaynshteyn, J.; Gerwin, J.; Heller, D.; Snuderl, M.
    Neuro-Oncology (2022)

    Fulltext@MSK | Save
  • Clinical outcome of pediatric medulloblastoma patients with Li-Fraumeni syndrome
    Meeting Abstract

    Kolodziejczak, A.; Guerrini-Rousseau, L.; Planchon, J. M.; Ecker, J.; Selt, F.; Mynarek, M.; Obrecht, D.; Sill, M.; Hirsch, S.; Sturm, D.; more...
    Neuro-Oncology (2022)

    Fulltext@MSK | Save
  • Selumetinib in pediatric patients with non-neurofibromatosis type 1-associated, nonoptic pathway (OPG) and non-pilocytic recurrent/ progressive low-grade glioma harboring BRAFV600E mutation or BRAF-KIAA1549 fusion: A multicenter prospective Pediatric Brain Tumor Consortium (PBTC) phase 2 trial
    Meeting Abstract

    Fangusaro, J.; Onar-Thomas, A.; Poussaint, T. Y.; Lensing, S.; Wu, S.; Ligon, A. H.; Lindeman, N.; Stewart, C. F.; Jones, D. T. W.; Pfister, S. M.; more...
    Neuro-Oncology (2022)

    Fulltext@MSK | Save
  • Nivolumab with or without ipilimumab in pediatric patients with high-grade CNS malignancies: Efficacy, safety, biomarker, and pharmacokinetic results from Checkmate 908
    Meeting Abstract

    Dunkel, I. J.; Cohen, K.; Foreman, N. K.; Hargrave, D.; Lassaletta, A.; AndreĢ, N.; Hansford, J. R.; Hassall, T.; Eyrich, M.; Gururangan, S.; more...
    Neuro-Oncology (2022)

    Fulltext@MSK | Save
  • Radiation induced high grade gliomas: A single center experience
    Meeting Abstract

    Joshirao, M.; Sait, S. F.; Bouvier, N.; Hill, K.; Khakoo, Y.; Kramer, K.; Gilheeney, S.; Wolden, S.; Nolan, C.; Schaff, L.; more...
    Neuro-Oncology (2022)

    Fulltext@MSK | Save
  • Clinical characteristics and clinical evolution of a large cohort of pediatric patients with primary central nervous system (CNS) tumors and tropomyosin receptor kinase (TRK) fusion
    Meeting Abstract

    Lamoureux, A. A.; Fisher, M.; Lemelle, L.; Pfaff, E.; Kramm, C.; De Wilde, B.; Kazanowska, B.; Hutter, C.; Pfister, S. M.; Sturm, D.; more...
    Neuro-Oncology (2022)

    Fulltext@MSK | Save
  • Phase 2 study of veliparib and local irradiation, followed by maintenance veliparib and temozolomide, in patients with newly diagnosed highgrade glioma without H3 K27M or BRAF Mutations: A report from the Children's Oncology Group ACNS1721 study
    Meeting Abstract

    Karajannis, M.; Onar-Thomas, A.; Baxter, P.; Butingan, N.; Fuller, C.; Gajjar, A.; Haque, S.; Jabado, N.; Lin, T.; Lucas, J.; more...
    Neuro-Oncology (2022)

    Fulltext@MSK | Save